Olema Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | — | $3.1M |
| Dec 2019 | — | — | $68.0K |
| Mar 2020 | — | — | $27.9M |
| Jun 2020 | — | — | $50.5M |
| Sep 2020 | — | — | $127.8M |
| Dec 2020 | $4.6M | $342.7M | $338.5M |
| Mar 2021 | $5.3M | $331.3M | $47.9M |
| Jun 2021 | $8.1M | $322.2M | $50.4M |
| Sep 2021 | $8.9M | $309.8M | $25.6M |
| Dec 2021 | $11.4M | $295.9M | $13.8M |
| Mar 2022 | $12.3M | $277.4M | $21.5M |
| Jun 2022 | $14.3M | $250.6M | $24.5M |
| Sep 2022 | $14.3M | $232.0M | $26.8M |
| Dec 2022 | $18.1M | $215.6M | $23.7M |
| Mar 2023 | $20.8M | $195.8M | $40.9M |
| Jun 2023 | $16.0M | $177.6M | $35.0M |
| Sep 2023 | $17.7M | $292.8M | $117.4M |
| Dec 2023 | $23.1M | $276.9M | $68.5M |
| Mar 2024 | $27.4M | $263.7M | $33.7M |
| Jun 2024 | $27.4M | $254.6M | $16.9M |
| Sep 2024 | $31.3M | $230.2M | $35.9M |
| Dec 2024 | $42.0M | $451.0M | $139.5M |
| Mar 2025 | $26.2M | $409.6M | $50.6M |
| Jun 2025 | $36.8M | $382.0M | $52.5M |
| Sep 2025 | $45.0M | $352.5M | $35.3M |
| Dec 2025 | $54.9M | $533.4M | $48.3M |
| Mar 2026 | $50.2M | $530.6M | $52.5M |
| Jun 2026 | $56.0M | $486.6M | $48.6M |